Jianhui Zhong
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Brain | 13 | 2000 | 305 |
Why?
|
Diffusion Magnetic Resonance Imaging | 6 | 2004 | 25 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 2004 | 74 |
Why?
|
Magnetic Resonance Imaging | 14 | 2000 | 295 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2003 | 139 |
Why?
|
Algorithms | 5 | 2007 | 226 |
Why?
|
Diffusion Tensor Imaging | 2 | 2009 | 13 |
Why?
|
Image Enhancement | 6 | 2000 | 71 |
Why?
|
Phantoms, Imaging | 6 | 2000 | 41 |
Why?
|
Brain Mapping | 5 | 2000 | 61 |
Why?
|
Whole Body Imaging | 2 | 2010 | 2 |
Why?
|
Macaca mulatta | 2 | 2008 | 71 |
Why?
|
Oxygen | 2 | 2002 | 180 |
Why?
|
Sensitivity and Specificity | 7 | 2000 | 427 |
Why?
|
Neural Pathways | 1 | 2009 | 48 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 58 |
Why?
|
Spin Labels | 1 | 2007 | 6 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 48 |
Why?
|
Quantum Theory | 2 | 2001 | 8 |
Why?
|
Electromagnetic Fields | 1 | 2007 | 14 |
Why?
|
Models, Chemical | 1 | 2007 | 57 |
Why?
|
Reproducibility of Results | 4 | 2008 | 392 |
Why?
|
Models, Molecular | 1 | 2007 | 102 |
Why?
|
Abdomen | 1 | 2004 | 51 |
Why?
|
Brain Neoplasms | 3 | 2010 | 116 |
Why?
|
Blood | 1 | 2002 | 67 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2003 | 29 |
Why?
|
Carbon Dioxide | 1 | 2003 | 91 |
Why?
|
Humans | 22 | 2000 | 1858 |
Why?
|
Diffusion | 1 | 2001 | 49 |
Why?
|
Hearing | 1 | 2001 | 20 |
Why?
|
Temporal Lobe | 1 | 2001 | 41 |
Why?
|
Glioma | 2 | 2010 | 51 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2000 | 39 |
Why?
|
Models, Statistical | 2 | 2008 | 114 |
Why?
|
Cognition Disorders | 2 | 2008 | 108 |
Why?
|
Equipment Design | 2 | 2001 | 132 |
Why?
|
Computer Simulation | 2 | 2007 | 134 |
Why?
|
Neoplasms | 1 | 2003 | 239 |
Why?
|
Female | 13 | 2003 | 1646 |
Why?
|
Anisotropy | 3 | 2006 | 23 |
Why?
|
Male | 12 | 2003 | 1558 |
Why?
|
HIV-1 | 2 | 2009 | 93 |
Why?
|
Diagnostic Imaging | 2 | 2010 | 66 |
Why?
|
HIV Infections | 2 | 2009 | 137 |
Why?
|
Adult | 9 | 2003 | 1321 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2011 | 9 |
Why?
|
Normal Distribution | 1 | 2011 | 13 |
Why?
|
Perfusion | 1 | 2011 | 73 |
Why?
|
Acoustic Stimulation | 2 | 2001 | 50 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 70 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2010 | 20 |
Why?
|
Aspartic Acid | 1 | 2010 | 37 |
Why?
|
Radiotherapy, Conformal | 1 | 2010 | 12 |
Why?
|
Blood Volume | 1 | 2010 | 35 |
Why?
|
Databases, Factual | 1 | 2011 | 103 |
Why?
|
Dacarbazine | 1 | 2010 | 18 |
Why?
|
Animals | 5 | 2001 | 1032 |
Why?
|
Mathematics | 2 | 2000 | 75 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 110 |
Why?
|
Glioblastoma | 1 | 2010 | 44 |
Why?
|
Fatigue | 1 | 2010 | 48 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 18 |
Why?
|
Lithium Compounds | 1 | 2009 | 10 |
Why?
|
Uncertainty | 1 | 2009 | 14 |
Why?
|
Endocardial Fibroelastosis | 1 | 2008 | 1 |
Why?
|
Propanolamines | 1 | 2008 | 12 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2008 | 8 |
Why?
|
Carbazoles | 1 | 2008 | 21 |
Why?
|
Biological Markers | 1 | 2010 | 263 |
Why?
|
Monte Carlo Method | 1 | 2008 | 40 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 47 |
Why?
|
Young Adult | 1 | 2011 | 381 |
Why?
|
Middle Aged | 6 | 2003 | 1166 |
Why?
|
Adenocarcinoma | 1 | 2010 | 167 |
Why?
|
Axons | 1 | 2007 | 67 |
Why?
|
Brain Injuries | 1 | 2007 | 50 |
Why?
|
Auditory Cortex | 1 | 2006 | 18 |
Why?
|
Alzheimer Disease | 1 | 2008 | 72 |
Why?
|
Artifacts | 1 | 2004 | 34 |
Why?
|
Knee Joint | 1 | 2003 | 30 |
Why?
|
Neuropsychological Tests | 3 | 2007 | 114 |
Why?
|
Prefrontal Cortex | 1 | 2003 | 13 |
Why?
|
Functional Laterality | 1 | 2003 | 50 |
Why?
|
Mental Recall | 1 | 2003 | 36 |
Why?
|
Regional Blood Flow | 1 | 2003 | 106 |
Why?
|
Memory | 1 | 2003 | 61 |
Why?
|
Oxygen Consumption | 1 | 2001 | 86 |
Why?
|
Leg | 1 | 2000 | 75 |
Why?
|
CD4 Lymphocyte Count | 2 | 2009 | 50 |
Why?
|
Treatment Outcome | 3 | 2008 | 662 |
Why?
|
Pilot Projects | 2 | 2007 | 265 |
Why?
|
Aged | 3 | 2008 | 992 |
Why?
|
Mice | 1 | 2004 | 623 |
Why?
|
Rats | 1 | 2001 | 532 |
Why?
|
Aged, 80 and over | 2 | 2008 | 602 |
Why?
|
Dobutamine | 1 | 2011 | 19 |
Why?
|
Cardiac Output | 1 | 2011 | 48 |
Why?
|
Creatine | 1 | 2010 | 18 |
Why?
|
Swine | 1 | 2011 | 95 |
Why?
|
Aorta | 1 | 2011 | 69 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 30 |
Why?
|
Heart Ventricles | 1 | 2011 | 86 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 112 |
Why?
|
Biopsy | 1 | 2010 | 208 |
Why?
|
Longitudinal Studies | 1 | 2010 | 195 |
Why?
|
Glycoproteins | 1 | 2010 | 113 |
Why?
|
RNA, Viral | 1 | 2010 | 91 |
Why?
|
Viral Load | 1 | 2009 | 53 |
Why?
|
Antidepressive Agents | 1 | 2009 | 46 |
Why?
|
Double-Blind Method | 1 | 2010 | 274 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 176 |
Why?
|
Survival Analysis | 1 | 2010 | 206 |
Why?
|
Survival Rate | 1 | 2010 | 250 |
Why?
|
Incidence | 1 | 2010 | 337 |
Why?
|
Heart Failure | 1 | 2011 | 106 |
Why?
|
Recovery of Function | 1 | 2007 | 91 |
Why?
|
Case-Control Studies | 1 | 2008 | 284 |
Why?
|
Logistic Models | 1 | 2008 | 254 |
Why?
|
Reference Values | 1 | 2006 | 281 |
Why?
|
Quality of Life | 1 | 2007 | 188 |
Why?
|
Reading | 1 | 2003 | 17 |
Why?
|
Aging | 1 | 2008 | 275 |
Why?
|
Infant | 1 | 2008 | 464 |
Why?
|
Child, Preschool | 1 | 2008 | 555 |
Why?
|
Learning | 1 | 2003 | 66 |
Why?
|
Cognition | 1 | 2003 | 98 |
Why?
|
Child | 1 | 2008 | 750 |
Why?
|
Adolescent | 1 | 2007 | 892 |
Why?
|
